Apollo Hospitals Q4 results reported a 54% YoY rise in consolidated net profit to ₹389.6 crores from ₹253.8 crores in the fourth quarter of the previous financial year. On a full-year basis, Apollo Hospitals made a net profit of ₹1,445.9 crores in FY25, a growth of 61% from ₹898.6 crores in FY24.
On the Apollo Hospitals results date, i.e., on May 30, Apollo Hospitals share price closed with a 0.62% fall at ₹6,880.50. In the last 5 years, the Apollo Hospitals share price has delivered more than 400% returns.
Apollo Hospitals Q4 Results FY25: Key Highlights
- In Q4 Apollo Hospitals quarterly results, consolidated revenue rose by 13% YoY to ₹5,592.2 crores from ₹4,943.9 crores in the fourth quarter of the previous year.
- EBITDA stood at ₹769.8 crores, up 20% YoY in Q4 FY25.
- EBITDA margin came at 13.8%, as compared to 13% in Q4 of FY25.
WHY SMC
- 20 Lac+ unique clients
- 33+ Years of Serving
- Advance Technical Analysis
- Free Demat Account
| Particulars (in ₹ Cr) | Q4 FY25 | Q4 FY24 | YoY Change |
|---|---|---|---|
| Net Profit | 389.6 | 253.8 | 53.51% |
| Revenue | 5,592.2 | 4,943.9 | 13.11% |
| EBITDA | 769.8 | 640.5 | 20.19% |
Apollo Hospitals Q4 Results: Segment-wise Performance
- As per Apollo Hospitals Q4 results, healthcare services revenue grew by 10% YoY to ₹2,822 crores. The net profit of this segment also increased to ₹385.1 crores in Q4 FY25 from ₹280.3 crores in the fourth quarter of the previous year.
- The Diagnostics & Retail Health segment revenue grew by 11% YoY to ₹394 crores. The loss of this segment reduced from ₹8.7 crores to ₹4.3 crores in the reported quarter.
- The Digital Health & Pharmacy Distribution revenue boosted by 17% YoY at ₹2,376 crores in the fourth quarter of FY25. In this segment, the company turned the ₹17.7 crores of losses made in Q4 FY24 into a profit of ₹8.8 crores in Q4 FY25.
| Segment Revenue (in ₹ Cr) | Q4 FY25 | Q4 FY24 | YoY Change |
|---|---|---|---|
| Healthcare Services | 2,821.9 | 2,562.6 | 10.12% |
| Diagnostics & Retail Health | 394.0 | 354.7 | 11.08% |
| Digital Health & Pharmacy Distribution | 2,376.3 | 2,026.7 | 17.25% |
Apollo Hospitals Q4 Results: FY25 Highlights
- In the financial year 2024-25, Apollo Hospitals’ consolidated revenue grew at a healthy rate of 14% YoY to ₹21,794 crores.
- EBITDA grew by 26% to ₹3,021.9 crores while EBITDA margin rose to 13.9% in the financial year 2024-25.
| Particulars (in ₹ Cr) | FY25 | FY24 | YoY Change |
|---|---|---|---|
| Net Profit | 1,445.9 | 898.6 | 60.91% |
| Revenue | 21,794.0 | 19,059.2 | 14.35% |
| EBITDA | 3,021.9 | 2,390.7 | 26.40% |
Apollo Hospitals Q4 Results: Dividend
Apollo Hospitals has declared a dividend of ₹10 per share (face value of ₹5 each) for the financial year ending March 31, 2025. The record date is set at August 19, 2025, while payment will be made on or before September 10, 2025.
So, open free Demat Account with SMC Global Securities to start your trading journey and stay updated with the Nifty 50 companies’ Q4 results.
Author: All Content is verified by SMC Global Securities.
WHY SMC
- 20 Lac+ unique clients
- 33+ Years of Serving
- Advance Technical Analysis
- Free Demat Account
